Advertisement

Topics

Agennix Company Profile

20:36 EST 15th November 2018 | BioPortfolio

Agennix is a privately held biotechnology company whose lead molecule, Talactoferrin Alfa (talactoferrin; TLF), is an immunomodulatory protein. Agennix is currently preparing to initiate Phase III development of oral talactoferrin for cancer, and topical talactoferrin gel for wound healing.
Liquid talactoferrin is an oral anti-cancer drug that has shown activity both as monotherapy and in combination with other chemotherapeutic agents. In non-small cell lung cancer (NSCLC), talactoferrin was evaluated in a Phase II, double-blind, placebo-controlled clinical trial where patients received standard first-line chemotherapy combined with either oral talactoferrin or placebo. The trial met its primary endpoint. Talactoferrin improved the relative confirmed response rate by 56% in the intent-to-treat population, and 62% in the prospectively defined evaluable population.

Location

8 Greenway Plaza, Suite 910
Houston
Texas
77046
United States of America

Contact

Phone: (713) 552-1091
Fax: (713) 552-0795
Email: dduke@agennix.com


News Articles [1 Associated News Articles listed on BioPortfolio]

Agennix AG i.L.: Preliminary announcement of the publication of quarterly reports and quarterly/interim statements

Agennix AG i.L. / Preliminary announcement on the disclosure of financial statements 22.10.2018 / 08:00 Preliminary announcement of the publication of quarterly reports and quarterly/interim statemen...

Drugs and Medications [0 Results]

None

PubMed Articles [1 Associated PubMed Articles listed on BioPortfolio]

Effects of talactoferrin alpha on lung adenoma prevention in A/J mice June 2, 2016.

Talactoferrin alpha is a promising non-toxic solid tumor cancer agent that met with success in the treatment of early-stage lung cancer clinically in humans. It is well-tolerated, anddendritic cell-st...

Clinical Trials [0 Results]

None

Companies [2 Associated Companies listed on BioPortfolio]

Agennix Incorporated

Agennix is developing this technology through the prototype stage in each application area. Prototype development includes overseeing the production of recombinant human lactoferrin, safety and toxici...

Agennix

Agennix is a privately held biotechnology company whose lead molecule, Talactoferrin Alfa (talactoferrin; TLF), is an immunomodulatory protein. Agennix is currently preparing to initiate Phase III dev...

More Information about "Agennix" on BioPortfolio

We have published hundreds of Agennix news stories on BioPortfolio along with dozens of Agennix Clinical Trials and PubMed Articles about Agennix for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Agennix Companies in our database. You can also find out about relevant Agennix Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Biotechnology - Biotech
"using living things to create products or to do tasks for humans" About Biotechnology - Biotech Biotechnology is the practice of using plants, animals and micro-organisms such as bacteria, as well as biological processes - such as the ripen...

Nutrition
Within medicine, nutrition (the study of food and the effect of its components on the body) has many different roles. Appropriate nutrition can help prevent certain diseases, or treat others. In critically ill patients, artificial feeding by tubes need t...

Clincial Trials
In a clinical trial or interventional study, participants receive specific interventions according to the research plan or protocol created by the investigators. These interventions may be medical products, such as drugs or devices; procedures; or change...


Corporate Database Quicklinks



Searches Linking to this Company Record